A Randomised Placebo-Controlled Trial to Investigate the Effect of Pre-treatment With Haem Arginate (Normosang) on Heme-Oxygenase 1 (HO-1) Upregulation in Recipients of Deceased Donor Kidneys
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Haem arginate (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms HOT
- 26 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 16 Mar 2015 New trial record
- 05 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.